🎉 Health Canada Provides a No Objection Letter for ATMA’s N500 Phase II Clinical Trial Application

Information Sessions

Our free 45-minute session with Q&A are designed for healthcare professionals who are interested in learning more about psychedelics.

Topics may include but not limited to: